Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies.

  • Howlett A
  • Mukhopadhyay S
  • Norford D
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Neuropathologies that affect our population include ischemic stroke and neurodegenerative diseases of immune origin, including multiple sclerosis. The endocannabinoid system in the brain, including agonists anandamide (arachidonyl ethanolamide) and 2-arachidonoylglycerol, and the CB1 and CB2 cannabinoid receptors, has been implicated in the pathophysiology of these disease states, and can be a target for therapeutic interventions. This review concentrates on cellular signal transduction pathways believed to be involved in the cellular damage.

Author-supplied keywords

  • Animals
  • Brain
  • Brain Diseases
  • Brain Diseases: metabolism
  • Brain Diseases: pathology
  • Brain: metabolism
  • Brain: pathology
  • Endocannabinoids
  • Endocannabinoids: metabolism
  • Humans
  • Reactive Nitrogen Species
  • Reactive Nitrogen Species: metabolism
  • Reactive Oxygen Species
  • Reactive Oxygen Species: metabolism
  • Receptors, Cannabinoid
  • Receptors, Cannabinoid: metabolism
  • Signal Transduction
  • Signal Transduction: physiology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Allyn C Howlett

  • Somnath Mukhopadhyay

  • Derek C Norford

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free